126 related articles for article (PubMed ID: 5216630)
21. [In vitro characteristics of largely genetically homogenous influenza virus A2 strains].
Gerth HJ
Arch Gesamte Virusforsch; 1970; 30(4):275-90. PubMed ID: 4318622
[No Abstract] [Full Text] [Related]
22. Meeting of the WHO expert working group on surveillance of influenza antiviral susceptibility, Geneva, July 2013.
Wkly Epidemiol Rec; 2013 Nov; 88(44/45):477-82. PubMed ID: 24236332
[No Abstract] [Full Text] [Related]
23. [Testing the antiviral properties of several compounds on the reproduction of the influenza virus using the immunofluorescent method].
Manolova N; Gagov I; Golovinska S; Serbezov V; Aleksandrov E
Izv Mikrobiol Inst (Sofiia); 1969; 20():203-8. PubMed ID: 4921360
[No Abstract] [Full Text] [Related]
24. A QSAR study on influenza neuraminidase inhibitors.
Verma RP; Hansch C
Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
[TBL] [Abstract][Full Text] [Related]
25. Tailor made sialidase inhibitors home in on influenza virus.
Corfield T
Glycobiology; 1993 Oct; 3(5):413-5. PubMed ID: 8286849
[No Abstract] [Full Text] [Related]
26. Clinical Implications of Antiviral Resistance in Influenza.
Li TC; Chan MC; Lee N
Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
[TBL] [Abstract][Full Text] [Related]
27. [Activity of bacterial, viral and mammalian neuraminidases].
Gielen W
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):235-6. PubMed ID: 4242387
[No Abstract] [Full Text] [Related]
28. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
[TBL] [Abstract][Full Text] [Related]
29. [Antiviral properties of adamantanamine].
Chernukh AM; Tolmacheva NS; Rudakova IS
Biull Eksp Biol Med; 1968 Mar; 65(3):88-91. PubMed ID: 5650469
[No Abstract] [Full Text] [Related]
30. [Antiviral properties of compounds of plant origin].
Loziuk LV
Mikrobiol Zh; 1977; 39(3):343-8. PubMed ID: 561296
[No Abstract] [Full Text] [Related]
31. [Study of antiviral properties of Calendula officinalis].
Bogdanova NS; Nikolaeva IS; Shcherbakova LI; Tolstova TI; Moskalenko NIu; Pershin GN
Farmakol Toksikol; 1970; 33(3):349-55. PubMed ID: 4318166
[No Abstract] [Full Text] [Related]
32. [Cyclic oxocompounds as potent antiviral agents].
Kraft MIa; Katyshkina VV; Pershin GN; Bogdanova NS
Farmakol Toksikol; 1966; 29(5):597-600. PubMed ID: 5995072
[No Abstract] [Full Text] [Related]
33. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
[TBL] [Abstract][Full Text] [Related]
34. [Experimental results with aimed synthetized substances for antiviral chemotherapy. 3. Indandione derivatives and beta ketosulfones].
Grafe A; Liebig H; Pfetzing H
Arzneimittelforschung; 1974 Jul; 24(7):1048-51. PubMed ID: 4368136
[No Abstract] [Full Text] [Related]
35. [Genetic markers and their interrelationships in influenza viruses. 3. The interrelationship between virulence and sensitivity to serum inhibitors, neuraminidase and eluting activity].
Sokolov MI; Shvachkina VI; Molibog EV
Vopr Virusol; 1970; 15(4):488-92. PubMed ID: 5505413
[No Abstract] [Full Text] [Related]
36. Neuraminidase activity of influenza virus-infected cells: localization and properties.
Orlova TG; Orlova NG
Acta Virol; 1975 Apr; 19(2):130-6. PubMed ID: 239558
[TBL] [Abstract][Full Text] [Related]
37. Anti-myxovirus activity of formycin B.
Ishida N; Izawa A; Homma M; Kumagai K; Shimizu Y
J Antibiot (Tokyo); 1967 Jul; 20(3):129-31. PubMed ID: 6072794
[No Abstract] [Full Text] [Related]
38. Isolation of a low molecular weight sialidase (neuraminidase) from influenza virus.
Seto JT BRZENIEK R; Rott R
Biochim Biophys Acta; 1966 Feb; 113(2):402-4. PubMed ID: 5942440
[No Abstract] [Full Text] [Related]
39. Studies on antiviral agents. IV. Synthesis and in vitro antiviral activity of new N-palmitoylkanamycin A derivatives.
Matsuda K; Yasuda N; Tsutsumi H; Takaya T
J Antibiot (Tokyo); 1986 Oct; 39(10):1479-82. PubMed ID: 3023267
[No Abstract] [Full Text] [Related]
40. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun C; Zhang X; Huang H; Zhou P
Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
